Clinical Trials
9 trialsNCT07131059 2025-08-20
MRD-positive AML Clinical Study
Institute of Hematology & Blood Diseases Hospital, China
Phase NA Recruiting
NCT06232694 2024-01-31
Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML
The First Affiliated Hospital with Nanjing Medical University
Phase NA Recruiting
NCT03173612 2022-08-03
The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Phase NA Unknown
NCT05053425 2022-04-26
Bcl-2 Inhibitors Combined With Azacytidine and Chemotherapy in Elderly Patients With Previously Untreated AML
LanZhou University
Phase NA Unknown
NCT05053386 2021-09-22
Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma
Zhejiang Cancer Hospital
Phase NA Unknown
NCT01296178 2021-03-23
PETHEMA-LMA10: Treatment of Acute Myeloblastic Leukemia (AML) in Patients Less Than or Equal to 65 Years
PETHEMA Foundation
Phase NA Unknown
NCT03390387 2020-02-05
ALL-MB 2015
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase NA Unknown
NCT01831232 2017-11-17
Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Fred Hutchinson Cancer Center
Phase NA Completed
NCT00317408 2015-09-25
Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI)
Phase NA Unknown